Fact-checked by Grok 2 weeks ago

Pyknosis

Pyknosis is a degenerative nuclear change observed in dying cells, characterized by the irreversible condensation and clumping of chromatin, resulting in a shrunken, hyperchromatic nucleus that stains densely under light microscopy. This process serves as a hallmark morphological feature in both apoptosis (programmed cell death) and certain forms of necrosis (uncontrolled cell death), reflecting underlying biochemical alterations such as DNA fragmentation and chromatin compaction. In apoptosis, pyknosis typically emerges early, often within hours of the initiation of signals, accompanying cytoplasmic shrinkage and compaction before progressing to (nuclear fragmentation) and the formation of membrane-bound apoptotic bodies that are phagocytosed without eliciting . This ordered sequence distinguishes apoptotic pyknosis from the more disorganized nuclear changes in , where initial cellular swelling and membrane rupture precede condensation, potentially leading to inflammatory responses due to the release of intracellular contents. Biochemically, apoptotic pyknosis involves caspase-mediated activation of endonucleases that cleave DNA at internucleosomal linker regions, producing the characteristic "laddering" pattern on , whereas necrotic pyknosis may reflect distinct pathways, such as those involving BAF (barrier-to-autointegration factor) and detachment from the . Pyknosis plays critical roles in physiological processes like embryonic development, tissue homeostasis, and immune regulation, where it facilitates the elimination of superfluous or damaged cells, as well as in pathological conditions including neurodegeneration, ischemia, and cancer therapy resistance. In neuroscience, for instance, pyknotic nuclei are prominent markers of neuronal loss in conditions such as stroke and Alzheimer's disease, aiding histopathological diagnosis through techniques like hematoxylin-eosin staining or TUNEL assays that detect DNA breaks. A 2016 study further delineated "necrotic pyknosis" as a regulated form of necrosis with unique molecular features, separate from classical apoptosis, highlighting its potential as a therapeutic target in inflammatory and degenerative diseases.

Definition and Characteristics

Definition

Pyknosis, also known as karyopyknosis, refers to the irreversible condensation of within the , resulting in a densely packed . This process represents a critical alteration in dying cells, where the aggregates into compact masses, distinguishing it from normal cellular states. The term originates from the word pyknos, meaning "dense" or "compact," which aptly describes the densification of observed in this phenomenon. primarily occurs in cells undergoing or , serving as an early indicator of in these forms of . As a hallmark of both programmed and unprogrammed pathways, it is irreversible once initiated, committing the to progressive dismantling. Under light , pyknotic nuclei appear as shrunken, hyperchromatic structures due to this condensation.

Morphological Features

Pyknosis is characterized by the progressive shrinkage of the , where condenses into a compact, dense mass, resulting in a small, rounded structure that stains intensely dark under light . This nuclear contraction reduces the overall nuclear volume significantly, while maintaining the general outline of the in early stages. The increased density arises from the tight packing of fibers, distinguishing pyknosis from other nuclear alterations like , where fading occurs instead. In hematoxylin and eosin (H&E) stained sections, the pyknotic nucleus exhibits a basophilic appearance, staining deep purple or blue due to the condensed, negatively charged chromatin that avidly binds hematoxylin. This dark staining contrasts with the surrounding cytoplasm, which may show eosinophilic (pink) changes, though the nuclear basophilia is the hallmark feature. The intense basophilia reflects the irreversible aggregation of histones and DNA, making pyknotic nuclei readily identifiable in routine histological examinations. Initially, the membrane remains intact, preserving the nuclear boundary despite the internal ; however, in advanced pyknosis, particularly during necrotic processes, the may detach transiently from the before collapsing onto it, leading to partial loss of integrity while the overall nuclear shape persists longer than in fragmentation stages. This phased progression allows for from rapid in other modes. Pyknotic nuclei are commonly observed in senescent leukocytes, where they appear as shrunken, basophilic masses amid apoptotic bodies, and in tumor s undergoing chemotherapy-induced , highlighting their role as a morphological in programmed elimination. Similar features are noted in neuronal tissues, such as in ischemic , where pyknotic neurons display compact, dark nuclei with preserved cytoplasmic .

Mechanisms of Pyknosis

Molecular Processes

Pyknosis involves the activation of specific endonucleases that initiate DNA fragmentation, leading to chromatin hypercondensation. In apoptotic cells, caspase-activated DNase (CAD), also known as DNA fragmentation factor 40 (DFF40), is released from its inhibitor ICAD upon caspase-3 cleavage, enabling CAD to enter the nucleus and cleave DNA at internucleosomal linker regions. This results in double-strand breaks that produce the characteristic 180-200 base pair DNA ladder and facilitate the compaction of chromatin into dense pyknotic structures. Studies demonstrate that CAD is both necessary and sufficient for this stage II chromatin condensation, as its inhibition prevents the hypercondensed morphology in isolated nuclei. Histone modifications, particularly deacetylation, play a crucial role in promoting packing during pyknosis by altering interactions and favoring a condensed state. deacetylases (HDACs) remove acetyl groups from residues on tails, reducing the negative charge and enabling tighter DNA- binding, which contributes to the epigenetic regulation of and pyknosis. This deacetylation is implicated in glial cell and , where it supports condensation without affecting neuronal cells similarly. Epigenetic analyses confirm that such modifications, alongside and non-coding RNAs, drive the irreversible nuclear shrinkage observed in pyknotic events. Degradation of nuclear s further contributes to pyknosis by destabilizing the , allowing to collapse inward. Caspase-mediated of lamin B1 occurs early in , preceding DNA fragmentation and correlating with chromatin condensation in thymocytes. This breakdown facilitates nuclear envelope disassembly, enabling the peripheral chromatin to aggregate centrally into pyknotic masses. Experimental evidence shows that inhibiting lamin degradation delays these nuclear events, underscoring its role in the morphological progression. In cells, hypercondensation represents a terminal event in both and certain necrotic pathways, marking the point of no return for integrity. Intense refractivity and shrinkage characterize this pyknosis as the common endpoint across these death modalities. Genetic studies in models provide evidence for distinct pyknotic forms, with apoptotic pyknosis involving caspase-dependent DNA degradation and necrotic pyknosis linked to barrier-to-autointegration factor (BAF) phosphorylation, supporting a morphological classification of . These findings from 2016 highlight biochemical differences, such as energy independence in necrotic cases, reinforcing pyknosis as a conserved yet varied molecular .

Biochemical Pathways

Pyknosis in apoptosis primarily arises through the intrinsic mitochondrial pathway, where pro-apoptotic BCL-2 family members such as BAX and BAK undergo oligomerization on the outer mitochondrial membrane, leading to its permeabilization (MOMP). This event releases cytochrome c into the cytosol, which binds to Apaf-1 to form the apoptosome complex, thereby activating initiator caspase-9. Caspase-9 subsequently cleaves and activates effector caspases, including caspase-3, which in turn processes substrates to drive DNA fragmentation via activation of endonucleases like CAD (caspase-activated DNase). In contrast, pyknosis during is triggered by metabolic perturbations such as severe ATP depletion, often coupled with dysregulated calcium influx through plasma membrane channels or mitochondrial dysfunction. This calcium overload activates non-caspase proteases, notably calpains, which degrade cytoskeletal and nuclear proteins, contributing to hypercondensation without ordered DNA laddering. Unlike the apoptotic , necrotic pyknosis proceeds via an energy-independent , as evidenced by its persistence even under ATP-depleted conditions that halt apoptotic progression. These pathways highlight a key biochemical distinction: apoptotic pyknosis requires ATP for caspase-mediated steps and precise chromatin remodeling, whereas necrotic hypercondensation relies on passive ion imbalances and protease activity independent of energy supply. Endonuclease activation, while central to apoptotic DNA breakdown, plays a minimal role in the disorganized fragmentation seen in necrosis.

Types of Pyknosis

Nucleolytic Pyknosis

Nucleolytic pyknosis represents a specific subtype of in which undergoes degradation through nuclease-mediated DNA fragmentation, typically resulting in discrete units of 180-200 base pairs that produce a characteristic internucleosomal "ladder" pattern observable via . This process distinguishes it as an active, enzyme-driven mechanism of pyknosis, contrasting with passive forms. The fragmentation occurs at linker regions between nucleosomes, leading to the breakdown of chromosomal DNA into oligonucleosomal-sized pieces, which is a hallmark biochemical event in regulated . Primarily associated with apoptosis, nucleolytic pyknosis involves internucleosomal cleavage initiated during the execution phase of this programmed cell death pathway. In apoptotic cells, caspases play a pivotal role by activating nucleases, thereby enabling the DNA degradation that characterizes this form of pyknosis. Key enzymes responsible include caspase-activated DNase (CAD), also referred to as DNA fragmentation factor 40 (DFF40), which is liberated from its inhibitor (ICAD) upon caspase-3-mediated proteolysis to execute the cleavage. DNase I has also been implicated in some cellular contexts as a contributor to this fragmentation, particularly in non-mammalian or specific stress-induced scenarios. Morphologically, nucleolytic pyknosis manifests as uniform clumping of chromatin into dense, refractile masses within the shrinking nucleus, ultimately leading to fragmentation into discrete pyknotic segments that are packaged into apoptotic bodies. This outcome reflects the organized dismantling of nuclear structure, where the cleaved DNA facilitates the condensation and segregation of chromatin. The distinct DNA laddering pattern on agarose gel electrophoresis serves as definitive evidence for this type, confirming the presence of regular internucleosomal breaks and differentiating it from non-fragmented nuclear changes.

Anucleolytic Pyknosis

Anucleolytic pyknosis represents a form of hypercondensation that occurs without enzymatic DNA fragmentation, characterized by non-enzymatic aggregation of driven by conformational changes in nucleosomal structures. This process lacks the involvement of endonucleases, distinguishing it from nucleolytic mechanisms, and instead relies on spontaneous entropy-driven sharing of tails between adjacent nucleosomes, leading to intense nuclear shrinkage. Primarily associated with unregulated necrotic cell death, anucleolytic pyknosis is triggered by stressors such as osmotic imbalances, toxic insults, metabolic stress from nutrient deprivation, or excitotoxic conditions that disrupt cellular homeostasis. These insults induce ion dysregulations, particularly calcium overload, which promote chromatin collapse without ordered cleavage. ATP depletion further facilitates this pathway by impairing energy-dependent protective mechanisms. Morphologically, it results in irregular, amorphous masses of condensed that form smaller, disorganized clumps, often accompanied by transient detachment of chromatin from the before collapse. In human under metabolic stress, this manifests as significant nuclear size reduction without fragmentation, observable after prolonged nutrient limitation and in pathological contexts like lesions. Biochemical studies in models have provided key evidence distinguishing anucleolytic pyknosis as a necrotic event, with genetic manipulations showing that of barrier-to-autointegration factor (BAF) specifically drives detachment and condensation in response to calcium overload via activation. Non-phosphorylatable BAF mutants suppress this pyknosis, enhancing larval survival from approximately 38% to 70% under necrotic induction, confirming its mechanistic separation from apoptotic forms. This event is conserved in cells, underscoring its role in necrotic progression. In excitotoxic scenarios, such as kainate exposure in spinal cord neurons, anucleolytic pyknosis is mediated by poly(ADP-ribose) polymerase-1 (PARP-1) activation, leading to nuclear translocation of apoptosis-inducing factor without involvement.

Role in Cell Death Pathways

Pyknosis in Apoptosis

Pyknosis represents an early morphological hallmark of , occurring shortly after mitochondrial outer membrane permeabilization (MOMP), which releases and activates effector leading to condensation. This condensation manifests as the nucleus shrinking into a dense, pyknotic mass, preceding , the subsequent fragmentation of the into apoptotic bodies. In this phase, the process is tightly regulated by caspase-mediated proteolysis, ensuring orderly nuclear dismantling without immediate plasma membrane rupture. Apoptosis, including its pyknotic stage, is an energy-dependent process requiring ATP for activation and cytoskeletal reorganization, distinguishing it from passive forms. This regulated execution renders immunologically silent, as apoptotic cells expose "eat-me" signals like to promote rapid , thereby preventing and facilitating remodeling. In developmental contexts, pyknosis aids sculpting of structures; for instance, during embryonic formation, interdigital mesenchymal cells undergo with visible pyknotic nuclei, eliminating to separate fingers and toes. Similarly, in immune regulation, negative selection of autoreactive thymocytes in the involves apoptotic pyknosis, eliminating self-reactive clones to maintain . If phagocytosis of pyknotic apoptotic cells fails, they progress to secondary , losing membrane integrity and releasing intracellular contents that can trigger . Recent insights integrate pyknosis into other regulated deaths, such as anoikis, where detachment from the induces MOMP and subsequent pyknotic condensation as a checkpoint against metastatic dissemination. In , this pyknosis typically reflects nucleolytic degradation driven by endonucleases like caspase-activated DNase.

Pyknosis in Necrosis

Pyknosis serves as the initial alteration in , occurring as an early response to severe cellular insults such as ischemia or exposure, where the condenses irreversibly before advancing to , the fading and dissolution of the . This hypercondensation reflects the breakdown of integrity under conditions of overwhelming stress, marking the onset of irreversible in affected tissues. Necrosis, including the pyknotic phase, is fundamentally unregulated and ATP-independent, driven by passive failure of cellular rather than enzymatic orchestration, which ultimately causes plasma membrane rupture and the passive leakage of intracellular contents. This rupture facilitates the release of damage-associated molecular patterns (DAMPs), such as high-mobility group box 1 () and heat shock proteins, from the compromised cells. The escaped DAMPs act as danger signals, triggering the recruitment and activation of immune cells like neutrophils and macrophages to the site of injury, thereby initiating a robust inflammatory that amplifies damage. In pathological contexts, pyknotic nuclei are prominent histological features in ischemic stroke, where they delineate zones of neuronal infarction following vascular , and in , signaling cardiomyocyte death within hours of coronary artery blockage. Biochemical investigations from 2016 have further delineated necrotic pyknosis as a distinct entity, characterized by extreme hypercondensation without fragmentation, reliant on barrier-to-autointegration factor (BAF) rather than activity, underscoring its divergence from other modalities. This anucleolytic form predominates in necrotic contexts.

Biological and Clinical Significance

Pathological Implications

Pyknosis manifests as a hallmark of in various pathological contexts, particularly in where it serves as an indicator of therapeutic response. In patients undergoing neoadjuvant , histopathological examinations reveal increased pyknotic nuclei within tumor cells, characterized by nuclear shrinkage and condensation, reflecting effective induction of or in malignant tissues. This observation underscores pyknosis as a morphological marker of treatment efficacy, as the presence of such nuclei correlates with tumor regression and reduced cellular viability following chemotherapeutic agents like or . In neurodegenerative disorders, pyknosis contributes to progressive neuronal loss driven by and necrotic pathways. In , necroptosis triggered by amyloid-beta accumulation and inflammatory signals leads to irreversible cell demise. Similarly, in , and mutant proteins like amplify cellular damage in the , contributing to dopaminergic loss. These changes highlight pyknosis's role in the chronic progression of neurodegeneration, where unchecked oxidative insults culminate in widespread neuronal attrition. Pyknosis also appears prominently in infectious diseases, linking pathogen-induced damage to pathology. During severe infections, studies of tongue epithelia show pyknotic nuclei indicative of viral-mediated , contributing to mucosal and systemic through direct cytopathic effects and inflammatory cascades. In bacterial infections, toxins such as toxin B from Clostridioides difficile provoke necrotic pyknosis in intestinal epithelial cells, characterized by rapid condensation independent of glucosylation activity, thereby driving and barrier dysfunction. Aberrant pyknosis disrupts normal embryonic development, contributing to congenital anomalies via dysregulated . Exposure to micronutrient deficiencies, such as , induces pyknotic nuclei in cranial cells of developing mouse embryos, impairing migration and differentiation, which results in craniofacial malformations like cleft palate. This excessive or mistimed pyknosis alters tissue patterning, emphasizing its pathological impact on . Therapeutically, modulating pyknosis-associated pathways offers promise for mitigating cell loss in ischemic conditions. In cerebral ischemia models, interventions like ischemic postconditioning reduce the incidence of pyknotic nuclei in hippocampal neurons by inhibiting necroptotic signaling via RIP3, thereby preserving tissue integrity and limiting infarct expansion. Targeting these mechanisms, including downstream effectors of , could prevent excessive neuronal death in , highlighting pyknosis as a modifiable in neuroprotective strategies.

Diagnostic Value

Pyknosis serves as a valuable prognostic indicator in clinical pathology, particularly through the quantification of pyknotic nuclei in tissue biopsies, which signals ongoing tissue injury or response to therapeutic interventions. In renal biopsies from patients with lupus nephritis, for instance, the scoring of tubular nuclear pyknosis—graded from 0 (absent) to 3+ (affecting >50% of tubular profiles)—contributes to the Tubulointerstitial Activity Index, correlating strongly with serum creatinine levels (r = 0.43 at initial biopsy, p < 0.001) and predicting outcomes such as end-stage renal disease more effectively than traditional indices. Similarly, in peripheral blood smears from COVID-19 patients, elevated counts of pyknotic cells correlate with high interleukin-6 levels (p = 0.003) and are associated with unfavorable disease progression (p = 0.005), aiding in the assessment of inflammatory severity and therapeutic efficacy. As a differentiation tool in reports, pyknosis facilitates the distinction between and , two pathways with contrasting implications— often being a controlled, beneficial process, while is uncontrolled and damaging. Morphologically, apoptotic pyknosis involves coordinated shrinkage of and the , leading to fragmentation into regular clumps, whereas necrotic pyknosis features detachment from the envelope followed by its collapse, observable in models like epithelial cells. Biochemically, necrotic pyknosis is marked by phosphorylation of barrier-to-autointegration factor (BAF) at 4, a process conserved across and inhibitable to reduce rates (e.g., from 30.4% to 14.4% in human cells under calcium stress), without affecting apoptotic pyknosis. These distinctions enable pathologists to classify modes accurately, informing treatment strategies in contexts like ischemia or . In , pyknotic changes provide a reliable means to estimate the () during autopsies, as nuclear shrinkage progresses predictably in tissues like gingival . Within 0-8 hours post-mortem, pyknosis emerges in superficial epithelial layers alongside and ; by 8-24 hours, it extends throughout the , correlating with increasing duration and environmental factors. This temporal progression supports estimation in early death investigations (up to 24 hours), though reliability is enhanced when combined with other autolytic changes, as no single feature is definitive due to variables like temperature. In research settings, quantifying pyknosis is instrumental for evaluating in models of aging and , offering insights into mechanistic pathways and intervention efficacy. In aging studies, liver models exposed to LED (simulating environmental stressors) demonstrate age-dependent pyknosis, with 36-week-old mice exhibiting higher nuclear pyknosis scores (1.25, p = 0.013) than 8-week-olds, alongside exacerbated and , highlighting pyknosis as a marker of age-vulnerable . In , models reveal necrotic pyknosis as a distinct for assessing chemical-induced damage, with BAF phosphorylation serving as a biochemical to differentiate it from , applicable to screening agents like ionophores. Despite its utility, pyknosis has limitations as a standalone diagnostic marker due to potential overlap with other forms of nuclear condensation, such as those in , necessitating complementary assays for specificity. Senescence involves chromatin reorganization, including decondensation of pericentromeric and erosion of the (e.g., reduced B1), which can mimic pyknotic-like density changes under microscopy, though pyknosis specifically denotes irreversible shrinkage toward . Markers like senescence-associated β-galactosidase or expression are thus required to differentiate these states, particularly in aging or contexts where both processes coexist.

Detection Techniques

Histological Methods

Histological methods for visualizing pyknosis primarily rely on techniques that highlight and changes in sections. These approaches allow pathologists to identify pyknotic nuclei as indicators of processes, such as or , within fixed and stained samples. Hematoxylin and eosin (H&E) staining is the most widely used routine method in for detecting pyknosis, where pyknotic nuclei appear as small, hyperchromatic (darkly stained) bodies due to the increased affinity of condensed for hematoxylin. In H&E-stained sections, these nuclei exhibit a shrunken, basophilic appearance against the , facilitating rapid identification in various s, including neural and epithelial samples. This technique is particularly effective for routine histopathological evaluation, as it provides a general overview of while accentuating abnormalities associated with pyknosis. Feulgen staining offers a more specific approach for highlighting DNA content, making it valuable for visualizing condensed chromatin in pyknotic nuclei. The method involves acid hydrolysis followed by Schiff's reagent, which reacts with depurinated DNA to produce a magenta color proportional to DNA density, thereby emphasizing the hyperchromatic regions of pyknotic structures. Studies have shown Feulgen staining to be superior to alternatives like Papanicolaou for demonstrating pyknosis in epithelial tissues, with significant differences in clarity (P=0.02). It is especially useful in research settings for precise DNA quantification alongside morphological assessment. Electron microscopy provides ultrastructural detail beyond light microscopy, revealing margination against the as a hallmark of pyknosis in dying cells. In transmission electron micrographs, pyknotic nuclei display dense, electron-opaque clumped along the periphery, often with nuclear shrinkage and loss of internal architecture, distinguishing apoptotic from necrotic forms. This technique has been instrumental in characterizing pyknosis in developing tissues, such as the , where margination varies by stage. Quantification of pyknotic nuclei under light microscopy involves counting or automated image analysis of stained sections to assess the extent of in a sample. methods tally hyperchromatic nuclei per , while software tools and count based on , , and , improving in large datasets. Automated approaches, such as those using fluorescent dyes on H&E equivalents, enable high-throughput evaluation of pyknotic indices in histopathological slides. These histological methods are cost-effective and integral to routine , offering accessible visualization without specialized equipment beyond standard microscopes. Recent 2024 advancements in , including AI-assisted whole-slide imaging, have enhanced pyknosis detection by automating nucleus segmentation and quantification across extensive tissue areas, boosting accuracy and efficiency in clinical diagnostics.

Biochemical and Molecular Assays

Biochemical and molecular assays provide quantitative measures of the molecular changes underlying pyknosis, particularly in nucleolytic forms where DNA fragmentation occurs, enabling confirmation of apoptotic or necrotic pathways beyond morphological observation. Gel electrophoresis serves as a foundational technique for detecting DNA laddering, a hallmark of nucleolytic pyknosis in apoptosis, where genomic DNA is cleaved into multiples of approximately 180 base pairs by endonucleases activated during cell death. In this assay, extracted DNA from cell lysates is separated on agarose gels, revealing a characteristic ladder pattern under UV light after ethidium bromide staining, distinguishing it from the random smearing seen in necrosis. This method, while qualitative, offers high sensitivity for confirming internucleosomal cleavage in pyknotic nuclei. The TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling) assay specifically targets DNA strand breaks associated with apoptotic pyknosis by incorporating labeled nucleotides at 3'-OH ends of fragmented DNA using terminal deoxynucleotidyl transferase. Performed on fixed cells or tissue sections, it allows visualization via fluorescence microscopy or flow cytometry, with positive staining indicating the double-strand breaks that accompany chromatin condensation in pyknosis. This assay is particularly useful for quantifying the extent of DNA damage in apoptotic contexts, though it may also detect some necrotic breaks, requiring combination with other markers for specificity. Caspase activity assays, such as fluorometric kits measuring cleavage of the DEVD substrate by effector caspases like caspase-3, detect the proteolytic cascades driving apoptotic pyknosis. In these assays, cell lysates are incubated with a fluorogenic peptide substrate, where increased fluorescence upon cleavage correlates with caspase activation, which precedes nuclear condensation and DNA fragmentation. This enzymatic readout provides a direct biochemical indicator of the apoptotic commitment leading to pyknosis, with kits often calibrated for high-throughput screening in research settings. Flow cytometry using DAPI (4',6-diamidino-2-phenylindole) staining quantifies nuclear condensation in pyknosis by assessing shifts in DNA content and intensity, as condensed binds more DAPI, resulting in brighter staining of sub-G1 populations. Cells are fixed, stained with , and analyzed for increased and peaks indicative of pycnotic nuclei, allowing simultaneous multiparametric assessment with other viability dyes. This approach enables precise enumeration of pyknotic cells in heterogeneous populations, supporting quantitative studies of dynamics. Recent advancements, such as high-throughput image processing software introduced in 2024, utilize algorithms for segmentation and tracking in DAPI-stained samples to study nuclear dynamics, including condensation, in assays. These tools facilitate automated analysis of nuclear architecture changes, enhancing reproducibility in large-scale studies of processes associated with pyknosis.

References

  1. [1]
    Apoptosis: A Review of Programmed Cell Death - PMC
    Pyknosis is the result of chromatin condensation and this is the most characteristic feature of apoptosis.
  2. [2]
    Apoptosis: A Basic Biological Phenomenon with Wide-ranging ... - NIH
    Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic ...
  3. [3]
    Pyknosis - an overview | ScienceDirect Topics
    Pyknosis, defined as the condensation and shrinkage of nuclear chromatin, is a prominent morphological feature observed in pathological neuronal death across ...
  4. [4]
    Molecular mechanisms of cell death - PubMed Central - NIH
    ... cell death into three different forms: (1) type I cell death or apoptosis, exhibiting cytoplasmic shrinkage, chromatin condensation (pyknosis), nuclear ...
  5. [5]
    Necrotic pyknosis is a morphologically and biochemically ... - PubMed
    Aug 15, 2016 · We devised genetic manipulations in Drosophila to study pyknosis, a process of nuclear shrinkage and chromatin condensation that occurs in apoptosis and ...Missing: definition pathology
  6. [6]
    Necrotic pyknosis is a morphologically and biochemically distinct ...
    Aug 15, 2016 · Pyknosis has been considered as an irreversible condensation of chromatin and the nucleus. It commonly occurs in both apoptotic and necrotic ...Missing: pathology | Show results with:pathology<|control11|><|separator|>
  7. [7]
  8. [8]
    Pyknosis - an overview | ScienceDirect Topics
    Pyknosis is defined as a process occurring in senescent leukocytes characterized by the condensation and fragmentation of the nucleus during programmed cell ...
  9. [9]
    The mechanisms of pyknosis: hypercondensation and death - PubMed
    Intense nuclear condensation with intense refractivity (pyknosis) is the ubiquitous terminus of all apoptosis and some necrosis of vertebrate cells.Missing: definition chromatin
  10. [10]
    Pyknosis Definition & Meaning - YourDictionary
    Origin of Pyknosis​​ From Ancient Greek πύκνωσις (puknōsis, “thickening" ), from πυκνός (puknos, “compact" ).
  11. [11]
    Pyknosis - an overview | ScienceDirect Topics
    Pyknosis is defined as a slow progressive degeneration of a cell characterized by nuclear shrinkage, leading to dense and deeply basophilic chromatin, resulting ...
  12. [12]
    Mechanisms and Morphology of Cellular Injury, Adaptation, and Death
    The hallmarks are pyknosis (nuclear condensation with shrinkage and intense basophilia), karyorrhexis (nuclear fragmentation), or karyolysis (nuclear ...
  13. [13]
    [PDF] Reversible and Irreversible Cell Injury - Doctor 2024 -
    • Pyknosis: shrinkage and increased basophilia;. • Karyorrhexis ... More blue staining using H&E of the nuclear material. Degradation of the nuclear ...
  14. [14]
    [PDF] General Pathology
    Pyknosis: characterized by nuclear shrinkage and increased basophilia. Here the chromatin condenses into a dense, shrunken basophilic mass. c. Karyorrhexis ...Missing: histology | Show results with:histology
  15. [15]
    Histology of the Central Nervous System - Robert H. Garman, 2011
    Nov 30, 2010 · The two central neurons have prominent eosinophilic cytoplasm, whereas the other two are primarily characterized by nuclear pyknosis. It is ...
  16. [16]
    Morphological and cytochemical determination of cell death by ... - NIH
    Frequently, the pyknotic nucleus assumes the appearance of a half-moon or crescent shape, a feature most indicative of an apoptotic cell (Fig. 1). Following ...
  17. [17]
    Caspase-activated DNase Is Necessary and Sufficient for ...
    Caspase-dependent apoptosis is a controlled type of cell death characterized by oligonucleosomal DNA breakdown and major nuclear morphological alterations.
  18. [18]
    The Contribution of Apoptosis-inducing Factor, Caspase-activated ...
    CAD is sufficient to induce both stage II chromatin condensation and LMW DNA degradation in isolated nuclei (14, 15). In growing cells, CAD remains inactive in ...
  19. [19]
    Contrasting nuclear dynamics of the caspase-activated DNase (CAD ...
    Nov 29, 2004 · CAD appears to be the most important apoptotic nuclease because chromatin condensation and DNA fragmentation were substantially delayed in ICAD− ...Missing: pyknosis | Show results with:pyknosis
  20. [20]
    Epigenetic regulation of necrosis and pyknosis - ResearchGate
    ... chromatin condensation occurred in apoptosis and necrosis. ... Epigenetic features include DNA methylation, histone modifications, non-coding RNAs, and chromatin ...
  21. [21]
    Epigenetic regulation of necrosis and pyknosis - ScienceDirect.com
    Here, we briefly review our current understanding of epigenetic control of necrosis and pyknosis. Epigenetic alterations such as DNA methylation, histone ...
  22. [22]
    Degradation of Lamin B1 Precedes Oligonucleosomal ... - PubMed
    Our results demonstrate that lamin degradation is an early feature of apoptosis in thymocytes and suggest that chromatin condensation and breakdown of the ...Missing: pyknosis | Show results with:pyknosis
  23. [23]
    Lamin proteolysis facilitates nuclear events during apoptosis.
    Dec 15, 1996 · Lamin breakdown by proteolytic degradation facilitates the nuclear events of apoptosis perhaps by facilitating nuclear breakdown.
  24. [24]
    The Mechanisms of Pyknosis: Hypercondensation and Death
    Intense nuclear condensation with intense refractivity (pyknosis) is the ubiquitous terminus of all apoptosis and some necrosis of vertebrate cells, ...
  25. [25]
  26. [26]
    Regulatory role of calpain in neuronal death - PMC - PubMed Central
    Calpains, calcium-dependent proteases, play a key role in neuronal death by affecting apoptosis, autophagy, and necrosis pathways.
  27. [27]
    Quantitative spectrofluorometric assay detecting nuclear ... - Nature
    Jun 7, 2021 · Nucleolytic pyknosis mainly occurs during apoptosis. Chromatin is condensed into large clumps which can be packed into apoptotic bodies. In ...Results · Cell Culture And Treatment · Caspase 3/7 Activity...<|control11|><|separator|>
  28. [28]
    A caspase-activated DNase that degrades DNA during apoptosis ...
    A caspase-activated deoxyribonuclease (CAD) and its inhibitor (ICAD) have now been identified in the cytoplasmic fraction of mouse lymphoma cells.Missing: nucleolytic pyknosis
  29. [29]
    The Mechanisms of Pyknosis: Hypercondensation and Death
    Nucleolytic pyknosis as per apoptosis was not intrinsic in this system and required exogenous nuclease. The pure anucleolytic pyknosis supported by this system ...
  30. [30]
    Mechanisms of metabolic stress induced cell death of human ...
    Jul 5, 2023 · Pyknosis can occur in two forms: nucleolytic and anucleolytic. Metabolic stress causes anucleolytic pyknosis [5]. We observed a significant ...
  31. [31]
    Kainate-mediated excitotoxicity induces neuronal death in the rat ...
    Neurons appeared to suffer chiefly through a process involving anucleolytic pyknosis mediated by strong activation of poly(ADP-ribose)polymerase-1 (PARP-1) ...
  32. [32]
    The Release of Cytochrome c from Mitochondria during Apoptosis of ...
    During apoptosis induced by various stimuli, cytochrome c is released from mitochondria into the cytosol where it participates in caspase activation.Missing: permeabilization | Show results with:permeabilization
  33. [33]
    Triple Fluorescence staining to Evaluate Mechanism-based ...
    Sep 4, 2018 · The spectrum of cytomorphological features of apoptosis in a timeline includes; cell shrinkage, rounding, and pyknosis of nucleus due to ...Triple Fluorescence Staining... · Live/dead Cell Assay · Results<|control11|><|separator|>
  34. [34]
    Apoptosis - StatPearls - NCBI Bookshelf
    The hallmark of apoptosis is pyknosis, in which nuclear chromatin condenses to form 1 or more dark-staining masses against the nuclear envelope. Dissolution ...Missing: timeline | Show results with:timeline
  35. [35]
    The essentials of developmental apoptosis - PMC - NIH
    Feb 26, 2020 · Histological analyses of developing embryos discovered that pyknotic (dying/dead) cells were present in certain locations at given stages of ...
  36. [36]
    Fas modulation of apoptosis during negative selection of thymocytes
    A major mechanism maintaining immune tolerance is the deletion of potentially autoreactive thymocytes by apoptosis during development in the thymus.
  37. [37]
    Secondary necrosis: The natural outcome of the complete apoptotic ...
    Oct 23, 2010 · For the same reason, secondary necrosis is the rule when in vitro cultured non-phagocytic cells from multicellular organisms undergo apoptosis.
  38. [38]
    Types of Cell Death from a Molecular Perspective - PMC
    Nov 13, 2023 · Inflammation and free radicals can stimulate cell self-destruction. Inflammation and cell death are vital aspects of most diseases.
  39. [39]
    Research progress on morphology and mechanism of programmed ...
    May 10, 2024 · Its main morphological features are nuclear micronization and polykeratosis (cell size becomes larger, forming giant cells containing two or ...
  40. [40]
    Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of ...
    In the absence of phagocytosis, apoptotic bodies may proceed to lysis and secondary or apoptotic necrosis. Autophagy features degradation of cellular ...
  41. [41]
    Release mechanisms of major DAMPs - PMC - PubMed Central
    DAMPs can be released passively by membrane rupture due to necrosis/necroptosis, although the mechanisms of release appear to differ between the DAMPs.
  42. [42]
    Early Reperfusion Following Ischemic Stroke Beneficial Effects
    Ischemic changes indicating cell death characterized by nuclear pyknotic changes were observed within the ischemic areas (B,E,H,K). At 1 d post stroke, ...
  43. [43]
    Evaluation of cardiac function at different time points after ...
    Oct 17, 2012 · Moreover, TEM illustration showed that nuclear pyknosis, myofilament disruption, mitochondrial swelling were present in all MI groups and severe ...
  44. [44]
    Histopathologic changes following neoadjuvant chemotherapy ... - NIH
    In the tumor cells, nuclear enlargement, nuclear shrinkage, necrosis, vacuolation of nucleus, cytoplasm, pyknotic nuclei, and degenerative changes have been ...
  45. [45]
    Inhibition of Alzheimer’s Disease Necroptosis Rescues Neurons
    Oct 30, 2024 · Neuronal death in Alzheimer's disease can be initiated by specific molecular signals, such as those of the necroptosis signaling pathway, ...
  46. [46]
    Parkinson's Disease-Associated Mutant LRRK2-Mediated Inhibition ...
    Additionally, we used Hoechst staining to analyze pyknotic nuclei, indicative of cell death. Previously, we have already shown that LRRK2 mutated at ...
  47. [47]
    Severe acute respiratory syndrome coronavirus 2 pathology and cell ...
    Jun 21, 2024 · This indicates that SARS-CoV-2 infection triggers pathological injury in the tongue, and that dysgeusis may be directly related to viral ...
  48. [48]
    TcdB of Clostridioides difficile Mediates RAS-Dependent Necrosis in ...
    Apr 12, 2022 · TcdB induces a necrotic cell death termed pyknosis in vitro independently from its glucosyltransferases, which are characterized by chromatin condensation and ...
  49. [49]
    Micronutrients and Congenital Anomalies* - WATANABE - 1990
    Histological examination of mouse embryos at midgestation showed that cranial neural crest cells were not migratory and demonstrated pyknotic nuclei in the ...
  50. [50]
    Ischemic Postconditioning Protects Against Global Cerebral ...
    Normal neurons had round and pale stained nuclei, whereas dying neurons in the ischemic areas showed pyknotic nuclei (Figure 2A). After 3 weeks of reperfusion, ...
  51. [51]
    RIP3 induces ischemic neuronal DNA degradation and programmed ...
    Jul 5, 2016 · IF investigation showed that Ac-DMQD-CHO did not inhibit the nuclear translocation of AIF and RIP3, axonal integrity and nuclear pyknosis (Fig.
  52. [52]
  53. [53]
    Changes in peripheral blood cellular morphology as diagnostic ...
    Jan 19, 2022 · High interleukin-6 (IL-6) levels were correlated to pyknotic cells (p = .003). Conclusion: The blood picture of COVID-19 patients revealed ...
  54. [54]
    Histological assessment of cellular changes in postmortem gingival ...
    Nuclear changes such as vacuolation, karyorrhexis, pyknosis and karyolysis became increasingly apparent with lengthening post–mortem intervals. Homogenizations ...
  55. [55]
    Hepatic inflammation, ballooning, and pyknosis caused by LED light ...
    Oct 1, 2024 · Hepatic inflammation, ballooning, and pyknosis caused by LED light exposure in a mouse model, with differential effects by age and gender.
  56. [56]
  57. [57]
    A Histochemical Comparison of Feulgen and Papanicolaou Stains ...
    ... Feulgen and Papanicolaou staining methods. The Feulgen was significantly more effective in demonstrating pyknosis compared to Papanicolaou (P=0.02).
  58. [58]
    Feulgen Staining Remains the Gold Standard for Precise DNA ...
    Aug 10, 2025 · The Feulgen stain can be used to detect DNA ploidy using computer-assisted image cytometry in an automated manner and applied in the diagnosis ...
  59. [59]
    Apoptosis in the central nervous system of developing mouse ...
    Electron microscopy of the pyknotic cells revealed the shrinkage of the cell body, to various degrees margination of the nuclear chromatin, condensation ...
  60. [60]
    Detection and Quantification of Nuclear Morphology Changes in ...
    We present a computerized method for apoptosis detection and quantification using images of fluorescent dye-stained cell nuclei.
  61. [61]
    Pyknotic Nuclei - TissueGnostics
    May 6, 2024 · High-throughput imaging is beneficial for detecting pyknotic nuclei in extensive tissue regions, improving the throughput and accuracy of ...
  62. [62]
    An update to DNA ladder assay for apoptosis detection - PMC - NIH
    The DNA ladder assay described here is a simple, sensitive, cost-effective and rapid method for estimating apoptosis in single cells.Missing: pyknosis biochemical
  63. [63]
    Identification of necrotic cell death by the TUNEL assay in the ...
    The morphological phenotype of apoptotic death consists of fragmentation of nuclei into sharply defined chromatin clumps, early preservation of cell membranes ...
  64. [64]
    TUNEL Apoptotic Cell Detection in Tissue Sections - Sage Journals
    1994): DNA hypercondensation (pyknosis) and the protein environment of DNA. ... (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic ...
  65. [65]
    PARP cleavage, DNA fragmentation, and pyknosis during ...
    Apoptotic neuronal cell death often involves activation of caspase-3 and/or calpains, which are involved in the subsequent cleavage of essential cellular ...
  66. [66]
    High-throughput image processing software for the study of nuclear ...
    Aug 8, 2024 · HiTIPS incorporates advanced image processing and machine learning algorithms for automated cell and nuclei segmentation, spot signal detection, ...